Screener
Bio-Rad Laboratories BIO Allowance for Doubtful Accounts Receivable (Current)
Allowance for Doubtful Accounts Receivable (Current) at other companies
Other financials
Where this comes from
Reported directly by Bio-Rad Laboratories in its filing.
Tagged under the XBRL concept us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent.
The source filing: Bio-Rad Laboratories’s 10-Q, filed April 30, 2026.
- Filed
- Apr 30, 2026, 4:19 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000012208-26-000035
| ASSETS | March 31, 2026 / (Unaudited) | December 31, 2025 |
|---|---|---|
| Current assets: | ||
| Cash and cash equivalents | $507.2 | $529.8 |
| Short-term investments | 1,057.5 | 1,010.9 |
| Accounts receivable, less allowance for credit losses of $4.9 and $5.5 as of March 31, 2026 and December 31, 2025, respectively | 426.2 | 460.6 |
| Inventory | 770.5 | 740.7 |
| Prepaid expenses | 150.0 | 136.5 |
| Other current assets | 30.7 | 27.7 |
| Total current assets | 2,942.1 | 2,906.2 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Bio-Rad Laboratories's allowance for doubtful accounts receivable (current)?
- Bio-Rad Laboratories (BIO) reported allowance for doubtful accounts receivable (current) of $4.9M in Q1 2026.
- How has Bio-Rad Laboratories's allowance for doubtful accounts receivable (current) changed year-over-year?
- Bio-Rad Laboratories's allowance for doubtful accounts receivable (current) decreased by 37.2% year-over-year, from $7.8M to $4.9M.
- What is the long-term trend for Bio-Rad Laboratories's allowance for doubtful accounts receivable (current)?
- Over 5 years (2020 to 2025), Bio-Rad Laboratories's allowance for doubtful accounts receivable (current) has grown at a -22.6% compound annual growth rate (CAGR), from $19.81M to $5.5M.
- What does allowance for doubtful accounts receivable (current) mean?
- This is the valuation allowance for current receivables that are considered uncollectible due to disputes, bankruptcy, or other non-payment issues. It serves as a buffer against potential losses from customer defaults. It is a critical indicator of the health of the company's accounts receivable portfolio.
Ask your AI about Bio-Rad Laboratories's allowance for doubtful accounts receivable (current).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude